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ABSTRACT  Ca  2+,  Mg2+-ionophores X537A  and  A23,187  (10-r-10 -6  M)  in- 
duced the release  of adenine nucleotides adenosine diphosphate (ADP,  aden- 
osine  triphosphate  (ATP),  serotonin,  /3-glucuronidase,  Ca  2+,  and  Mg  2+ from 
washed human platelets.  Enzymes present in the cytoplasm or mitochondria, 
and Zn  2+ were not released. The rate of ATP and Ca  2+ release measured by fire- 
fly lantern extract and murexide dye, respectively, was equivalent to that pro- 
duced  by  the  physiological  stimulant  thrombin.  Ionophore-induced  release 
of ADP, and serotonin was substantially (~60 %) but not completely inhibited 
by EGTA, EDTA,  and  high  extracellular  Mg  2+,  without  significant reduc- 
tion of Ca  2+ release. The ionophore-induced release  reaction is therefore partly 
dependent upon uptake of extracellular Ca  2+  (demonstrated using ~Ca), but 
also occurs to a significant extent due to release into the cytoplasm of intracel- 
lular Ca  2+. The ionophore-induced release reaction and aggregation of platelets 
could be  blocked  by prostaglandin El (PGE1)  or dibutyryl cyclic  AMP. The 
effects  of PGEx,  and N 6, O2-dibutyryl adenosine 3': 5'-cyclic  monophosphoric 
acid  (dibutyryl cAMP)  were  synergistically potentiated  by  the  phosphodi- 
esterase  inhibitor  theophylline. It  is proposed  that  Ca  ~+  is  the  physiological 
trigger for platelet secretion and aggregation and that its intraeellular effects 
are strongly modulated by adenosine 3':5'-cyclic monophosphoric acid (cyclic 
AMP). 
INTRODUCTION 
As an essential feature of their role in hemostasis platelets undergo a  physio- 
logical secretory process known as the "release reaction" in which the contents 
of certain intracellular granules are expelled into the surrounding medium. 
This occurs without damage or destruction to platelets since cytoplasmic con- 
stituents are  not released  (Holmsen and  Day,  1970).  Platelet secretion and 
aggregation are induced physiologically by low concentrations of the blood- 
clotting  enzyme,  thrombin,  or  by  platelet  interaction  with  subendothelial 
connective tissue components,  especially collagen.  Platelet aggregation may 
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be impaired by exposure to chemical substances which prevent platelet secre- 
tion  (Mustard  and  Packham,  1970),  such  as  aspirin  (acetylsalicyclic acid), 
indomethacin, and prostaglandin  E1  (PGE1).  Genetic defects in  the release 
reaction,  or  in  the  storage  pool  of adenine  nucleotides  and  serotonin,  are 
associated with impaired aggregation and bleeding tendencies (Weiss,  1972; 
Hardisty and Mills,  1972).  Platelet aggregation is  also dependent upon the 
presence of certain protein factors present in plasma  (Cross,  1964;  Mustard 
et al.,  1972;  Bang et al.,  1972)  or released from within  the platelet  (Miller 
et al.,  1975). 
Although  human  platelet  aggregation  requires  the  presence  of Ca  2+  the 
release reaction induced by some agents, such as thrombin, occurs unimpaired 
in the absence of Ca  2+ in the medium (Morse et al.,  1965; Miller et al.,  1975). 
Since the requirement for Ca  2+ in cellular secretory processes appears to be so 
universal  (Rubin,  1970),  it is logical to suspect that an intracellular pool of 
calcium may be mobilized  in  such  instances where a  requirement of extra- 
cellular  Ca  2+  cannot  be  demonstrated.  The  blood  platelet  contains  much 
stored calcium, a  large proportion of which is released during the secretory 
process (Mfirer,  1969; Detwiler and Feinman,  1973; Miller et al.,  1975),  but 
no  influx of Ca  ~+ preceding thrombin-induced secretion has  been  observed 
(Robblee et al.,  1973  b).  The hypothesis that Ca  ~+ serves as a  trigger for the 
secretory process would be substantially enhanced if it could be shown that 
intracellular injection of Ca  2+  initiated  the event.  However,  the very small 
size of platelets precludes this approach. A  means of selectively altering Ca  2+ 
permeability could provide  the same sort of information.  Recently two  na- 
turally occurring ionophorous substances  (X537A  and  A23,187)  have  been 
described  which  act  as  highly  mobile  divalent  cation  carriers  (Pressman, 
1973)  and thereby transport Ca 2+ and Mg  ~+ down their thermodynamic ac- 
tivity  gradients  in  various  cell  organelles  such  as  mitochondria  and  sarco- 
plasmic reticulum (Reed and Lardy, 1972; Scarpa et al.,  1972; Entman et al., 
1972).  We have employed these ionophores to study the role of Ca  2+ in the 
platelet  release  reaction  and  the  ensuing  platelet  aggregation.  The  results 
indicate that  Ca  2+ is  the normal physiological trigger for the secretory and 
aggregation processes in platelets, and that its effects are strongly mQdulated 
by adenosine 3' : Y-cyclic monophosphoric acid (cyclic AMP) within the cells. 
METHODS 
Platelet Preparations 
Four different types of platelet  preparations  were utilized: (a) platelet-rich plasma 
(PRP) obtained from freshly drawn human blood,  (b) human platelet concentrates 
obtained  from the  Connecticut Red  Cross  Blood  Center,  Farmington,  Conn.  (c) 
washed human platelets suspended in a buffered physiological salt solution, and (d) 
washed human platelets suspended in a buffered physiological salt solution containing 
serum albumin and low concentrations of potato apyrase. FEINSTEIN AND  FRASER  Human Platelet Secretion and Aggregation  563 
PRP was prepared from freshly drawn blood anticoagulated with  3.8 %  (wt/vol) 
trisodium citrate solution at a concentration of 1 vol to 9 vol of blood,  or with acid- 
citrate-dextrose (ACD) solution (1:6 vol/vol) of Aster and Jandl (1964). Centrifuga- 
tion at room temperature in plastic tubes for 15 min at  120 g yielded PRP.  Washed 
platelets were  prepared from Red  Cross platelet  concentrates anticoagulated  with 
ACD  (Miller  et al.,  1975)  and were suspended  in  a  medium containing  137  mM 
NaC1, 2.7 mM KCI, 0.2 %  (wt/vol) dextrose, and pH adjusted to 7.5 with 25 mM 
Tris-HC1.  In an alternate procedure the wash medium and all subsequent solutions 
contained 4 mg/ml bovine serum albumin  (Cohn  fraction V, Sigma Chemical Co., 
St. Louis, Mo.) and 50/~g/ml potato  apyrase (Type II, Sigma), a medium in which 
platelets maintain their normal discoid  shape  (Mustard  et al.,  1972).  Platelet con- 
centrates in ACD-plasma were also employed after dilution three- to sixfold with the 
Tris-buffered physiological salt solution containing albumin  and  apyrase described 
above. 
Protein was determined by a  biuret method (Gornall et al.,  1949)  in concentrated 
washed platelet suspensions which were then adjusted to a concentration of  1.0-rag 
platelet protein/ml by dilution with the buffered salt solution.  Platelet counts were 
made with  a  Technicon Platelet Counting  System  (Technicon Instruments  Corp., 
Tarrytown, N. Y.). A value of 1.8  -4- 0.2 (mean -4- SE) mg protein per 109 platelets 
was found, in close agreement with Holmsen and Day (1970). 
Platelet Aggregation 
Platelet aggregation was studied by the turbidimetric method of Born (1962), utilizing 
a Turner 350 spectrophotometer (G. K. Turner Associates, Palo Alto, Calif.) modified 
to provide continuous stirring and maintenance  of constant temperature  (37°C)  as 
previously described by Miller et al. (1975). Aggregation results in an increase in the 
light transmittance of platelet suspensions. The supernatants  resulting from complete 
centrifugation of formed elements (3,000 g,  10 min) were used to set 100 %  transmit- 
tance. Zero transmittance was set with a blocking filter in the light path. 
Platelet Release Reaction 
SEROTININ  [3'-14C]Serotonin creatinine  sulfate  (Amersham/Searle  Corp.,  Ar- 
lington Heights, Ill.) with a specific activity of 57 mCi/mmol was added at a concen- 
tration of 0.02 ~Ci/ml to the platelet wash medium and uptake was allowed to proceed 
for 20 rain at 20-23°C. The normal washing procedure was then resumed providing 
essentially complete removal of any extracellular  [3'-14C]serotonin. Aliquots of cell 
suspensions  and  supernatants  were  dissolved  in  Aquasol  (New  England  Nuclear, 
Boston, Mass.)  and the radioactivity measured in a scintillation counter.  [14C]Sero- 
tonin was also incubated with PRP for 30-45 rain at 37°C. The radioactivity in the 
platelets was calculated  as the  difference between the total amount in PRP and that 
present in an aliquot  of platelet-free plasma obtained  after centrifugation of PRP at 
5,000 g for 5 rain. Under the prevailing conditions  85-90 %  of [3'-14C]serotonin was 
taken up into the platelets during the incubation period. Platelets were incubated with 
ionophores in siliconized test tubes at 37°C for the appropriate time  and then placed 
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platelet-free supernatant was  determined  after centrifugation  (3,000 g)  at O°C for 5 
min. Controls which did not receive ionophores were treated in the same way. 
ADENINE NUCLEOTIDES  ADP  was  measured  by the  NADH2-pyruvate kinase- 
lactate dehydrogenase coupled enzyme system (Miller et al.,  1975).  The rate of ATP 
release was determined  by the method  of Detwiler  and  Feinman  (1973).  The light 
output  due  to reaction  of  released  ATP with  firefly lantern  extract in  the  platelet 
suspension medium was measured  in a  Perkin-Elmer 356 spectrophotometer (Perkin- 
Elmer Corp., Instrument Div., Norwalk, Conn.) set in the energy mode and with 900 
V supplied to the photomultiplier tube (Miller et al., 1975). 
CALCIUM,  MAGNESIUM,  AND  ZINC  ASSAYS  Platelet  suspensions  (1.0  mg  total 
platelet protein) were heated in Vycor test tubes overnight at  180°C with 0.5  ml of 
concentrated  nitric  and  70 %  perchloric  acids,  1:I  (vol/vol).  The resulting dry ash 
was dissolved in 1.0 nil of 0.05 N HC1 containing 0.01 M  LaCI3. Calcium, magnesium, 
and zinc were determined by atomic absorption spectrophotometry. The calculations 
for cellular cation content were corrected for the amount of each cation in the extra- 
cellular fluid obtained by centrifugation of platelet suspensions at 3,000 g. The extra- 
cellular fluid and cation standards in platelet bufferwere adjusted to contain 0.01  M 
LaC13  and  0.05  N  HC1 before analysis.  The rate of calcium release  was also deter- 
mined  by the  murexide dye method  of Ohnishi  and  Ebashi  (1963)  as modified for 
platelet suspensions by Miller et al.  (1975). All glassware was washed in concentrated 
sulfuric acid saturated with sodium nitrate to reduce calcium contamination. 
45Ca UPTAKE  The  uptake  of calcium was  measured  in  washed  platelets  by 
the method of Mfirer and Holme (1970) employing *sCa as a tracer.  The suspension 
medium contained  1.0-rag platelet protein/ml and  1.0 mM calcium chloridO with a 
specific activity of 2.9  X  106 cpm/pmol. Under these conditions  release of platelet 
calcium into the medium could decrease the specific activity by only about 5 %. After 
the  appropriate  incubation  period  with  or without  A23,187  the  cells were rapidly 
separated from the medium by centrifuging at 8,000 g  (Eppendorf Microcentrifuge, 
model 3200)  through a sucrose gradient at 0°C for 30 s. A  duplicate  aliquot of cells 
was centrifuged through sucrose containing 0.1  mM EGTA to remove superficially 
bound  calcium.  The platelet pellets were washed  three  times with ice-cold 0.25  M 
sucrose,  or 0.25  M  sucrose  +  0.1  mM  EGTA, dissolved  in  1% Triton X-100  and 
Aquasol  and  the radioactivity determined  by liquid  scintillation.  Contamination  of 
the platelet pellets with extracellular fluid was assessed  by using  [14C]inulin  (7.7  X 
106 cpm/ml) as a marker. The corrections of 45Ca uptake amounted to an average of 
only 0.004 % and were therefore insignificant. 
ENZYME ASSAYS  Beta glucuronidase was assayed by the method of Fishman et al. 
(1965) with phenolphthalein glucuronide as the substrate. One unit of enzyme activity 
1 Calcium chloride was present at a concentration  of 1 mM rather  than  10-20 #M so as to avoid 
large changes in its specific activity due to the increase of about 50/zM calcium in the medium ex- 
pected as a result of the A23187-induced release reaction (see Table I). FEINSTEIN AND  FRASER  Human Platelet Secretion and Aggregation  565 
produced 1 /~mol of phenolphthalein  per minute at 37°C. Lactic dehydrogenase was 
measured by the method of Bergmeyer et al.  (1965).  Malate dehydrogenase activity 
was assayed by measuring the rate of NADH2 oxidation accompanying the reduction 
of oxaloacetate to malate (Bergmeyer and Bernt,  1965). Pyruvate kinase activity was 
assayed in the presence of ADP, phosphoenolpyruvate, lactate dehydrogenase,  and 
NADH, (Beisenherz  et al.,  1953). All pyridine nucleotide-linked enzyme assays were 
performed at 25°C in a  Perkin-Elmer 356 dual-beam spectrophotometer at 345 nm. 
One unit of enzyme results in an initial rate of NADH2 oxidation of 1 ~umol/min  at 
25°C. 
A23,187  and  X537A were generously supplied  by Dr.  David Wong of Eli  Lilly 
Co.,  Indianapolis,  Ind.  and  Dr. Julius Berger of Hoffman-LaRoche, Nutley,  N.J. 
PGE1 was a  gift of Upjohn Co.,  North  Haven,  Conn.  Thrombin  (250  U/mg)  and 
dibutyryl cyclic AMP were obtained from Sigma Chemical Co. Hirudin (2,400 Anti- 
Thrombin  [AT] U/mg) was a gift from Dr. D. Bagdy of the Research Institute for 
Pharmaceutical  Chemistry, Budapest, Hungary. 
RESULTS 
Ca ~+, Mg  2+ Release from  Washed Platelets 
The incubation  of washed human  platelets with either one of the ionophores 
( 1-5/~M) in a  medium without added divalent cations resulted in a rapid loss 
of a substantial portion of cellular calcium and magnesium into the incubation 
medium.  The  initial  extracellular  calcium  and  magnesium  concentrations 
ranged from  10-20/~M.  The amount of calcium released from washed plate- 
lets in 5 min at 37°C by either A23,187 or X537A was about 67% of the total 
platelet content  (Fig.  1).  The  same fraction  of the total platelet calcium was 
released by thrombin  (0.5 U/M),  or by cell lysis due to repeated freezing and 
thawing.  A23,187  also released  as  much  magnesium  (69%)  as freeze-thaw- 
induced  platelet  lysis.  Less magnesium  (39%)  was released  by X537A,  and 
very little (7.3%) by thrombin (Fig.  1). The latter finding indicates that only a 
small proportion,  if any, of the cellular  magnesium  content  is present  in  the 
secretory granules of human  platelets since under  these conditions  thrombin 
causedmaximal release of ptatelet nucleotides and 5 serotonin. Human platelets 
also contain a substantial amount of zinc (19.2  ~  0.9 nmol/mg protein,  seven 
experiments),  35%  of  which  was  released  upon  cellular  lysis.  However, 
neither  the  ionophores  (17  experiments)  nor  thrombin  (4  experiments) 
produced  any  detectable  release  of  this  cation.  The  relationship  between 
A23,187  concentration  and  release  of cellular  calcium  and  magnesium  is 
shown in Fig.  2.  The  threshold  for release was at about 5  ×  10  -s M  and  a 
plateau  in  the  response  was  reached  at  1  X  10 -e  M.  The  concentration- 
response  curves  for  the  two  cations  are  for  the  most  part  superirnposable. 
Approximately 2 tool of calcium were released for every mole of magnesium. 
This is somewhat greater  than  their molar ratios within  the cell  (Ca/Mg  = 566  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  66  •  1975 
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FIGURE  2.  Release  of calcium  and  magnesium  from  washed  human  platelets  in  a 
buffered salt solution, as a function of A23,187 concentration. Temperature 37°C, incu- 
bation time 10 rain. Values are means  4- standard errors for 8-12  experiments  for each 
point. 
1.73).  The  rate  of Ca  ~+  release  (Fig.  3 A)  measured  at  23 °  by the  murexide 
method  was found  to  coincide  with  the  rate  of release  induced  by thrombin 
(Detwiler  and  Feinman,  1973;  Miller  et  al.,  1975).  The  K  +  ionophores 
nigericin and valinomycin (1-5 #M)  did not induce release of platelet calcium FEINSTEIN AND FRASER  Human Platelet Secretion and Aggregation  567 
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FIGURE  3.  (A)  Spectrophotometer  measurement  of  calcium  release  from  washed 
human  platelets.  Nigericin  (2  /zM),  valinomycin  (2  /zM),  A23,187  (1.6  ~tM),  X537A 
(5 #M),  or thrombin  (0.5  U/ml) added to 3.0 ml of platelet buffer containing 250  /.tM 
murexide and  1 mg platelet protein/ml.  Calibration  responses  are 25  #M  additions  of 
calcium.  Temperature  23°C.  (B)  Release of platelet ATP measured  as  light  emission 
with  a  crude  firefly lantern  extract  (Detwiler and  Feinman,  1973)  in  the  incubation 
medium. Thrombin 0.5 U/ml (  ), A23,187,  1 #M ( ....  ). Temperature 23°C. 
(Fig. 3 A) or adenine nucleotide from washed platelets, nor did they have any 
effect on platelet aggregation. 
CALCIUM UPTAKE  The effect of A23,187  on 45Ca uptake in washed platelets 
was  determined over a  5-min  period  at  37°C.  The  4~Ca uptake  reached  a 
maximum within  60  s  2 after  addition  of the  ionophore  (2  #M),  and  was 
65-90%  complete within  45  s.  The  radioactivity at  60  s  increased from  a 
control  level  of  1,370  (±326)  cpm/mg  platelet  protein  to  11,531  (:t:336) 
cpm/mg in five experiments.  EGTA-washed platelets at 60  s contained  453 
(4-89)  and  3,311  (4-646)  cpm/mg,  respectively.  Background  was  10  cpm. 
The ionophore-induced apparent calcium uptake  calculated from the specific 
activity of Ca  2+,  and corrected for bound calcium removed  by EGTA,  was 
0.97  (4-0.03)  nmol  calcium/rag platelet  protein. ~ It  cannot be determined 
from the radioactivity data alone to what extent the calcium uptake  repre- 
sents increased net uptake or self-exchange. 
Release of Adenine Nudeotides and Serotonin from Washed Platelets 
A23,187  (1.6 #M) released 72% of the radioactive serotonin and 47% of the 
ADP in 5 rain at 37°C (Table I). The rate and total amount of ATP release at 
25°C induced by thrombin and A23,187  are nearly identical (Fig.  3 B).  The 
same observation was made recently by Feinman and Detwiler (1974). 
2 Samples taken at 30 s after addition of ionophore, plus 30 s centrifugation time. 
3 At an initial extracellular calcium level of 25/z M  a net calcium uptake of 0.04 nmol/mg in 1 rain 
was found. This was calculated assuming an average extracellular calcium level of 50/zM as a result 
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TABLE  I 
EFFECTS  OF  EGTA,  EDTA,  AND MAGNESIUM ON  A23,187-INDUCED  RELEASE  OF 
ADP,  Ca 2+,  AND  Mg 2+ 
ADP  Calcium  Magnesium 
Total  Cell Content*  14.25  (4-0.4)  78.2  (4-3.2)  45.4  (4-2.3) 
Released by : 
A23,187  (l.6/zM)  6.72  (4-0.6)  51.3  (4-1,6)  29.7  (-4-1.0) 
A23,187-t-  EGTA  (1  mM)  2.71  (4-0.4)  48.7  (4-3,2)  19.5  (4-1.1) 
A23,187-t-  EDTA  (1  mM)  2.90  (4-1.3)  45.3  (4-2,4)  26.1  (-4-1.1) 
A23,187  -t- Mg 2+  (1.3 mM)  1.56  78.2  (-4-8,5)  -- 
3.12 
* Concentrations (mean 4- SE, for 6-14 experiments) are expressed in nanomoles per milligram 
of platelet protein. Washed platelets were incubated for  10 min at 37°C with A23,187.  EGTA, 
EDTA,  or Mg  ~+ were added 2 min before A23,187. The supernatant solutions were analyzed as 
described in Methods. 
Release of Cellular Enzymes 
The total cellular activity of lactate dehydrogenase and pyruvate kinase was 
found in the 40,000 g (30 min) supernatant after disruption of the platelets by 
sonication. About 80% of lactate dehydrogenase, 43% of pyruvate kinase, and 
65% of malate dehydrogenase activity was found in  the soluble  supernatant 
after  centrifugation  (10,000  g)  of three-times  freeze-thaw lysed  cells.  The 
incubation medium of untreated cells usually contained no more than 0.5% 
of each of the enzyme activities of the sonicated cell suspension. After exposure 
of platelets  to  0.5  U/ml  thrombin  the  enzyme activity  appearing  in  the 
medium amounted only  to  about  0.6-1.7%  of the  total  cellular  content. 
A23,187  or X537A  (1-2  #M)  slightly increased the levels of these enzymes 
appearing in the incubation medium (no added protein present), to about an 
additional 2% in the case of lactate dehydrogenase and 1-1.5% for the other 
enzymes (Fig.  4).  Thus, these enzymes which are essentially retained within 
platelets during the release reaction elicited by thrombin are also not released 
to any substantial extent by the ionophore. The /3-glucuronidase activity of 
washed human platelets lysed by 0.5% Triton X-100 hydrolyzed phenolph- 
thalein  glucuronide at  a  rate  of  1.3  nmol/min/108 cells.  /3-Glucuronidase, 
located in  the lysosomal-like a  granules of the platelet,  was released to  the 
extent of about  10%  of its  total  cellular activity by exposure to  1.0  U/ml 
thrombin (Mills et al.,  1968), and in our experiments 8-11% was released by a 
10-min exposure to 0.7-1.4 #M A23,187 at 37°C. 
In the presence of added albumin the concentration of X537A or A23,187 
had to b e increased severalfold to elicit the release reaction. This was due to 
binding of the ionophores to  albumin, which was demonstrated by fluores- 
cence spectroscopy. No significant differences in enzyme release were noted in FEINSTEIN AND  FRASER  Human  Platelet Secretion and Aggregation  569 
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FIGURE 4.  Release of platelet enzymes. Washed human platelets incubated in a buffered 
salt solution at 37°C with X537A (5 #M), A23,187 (1.6/~M), or thrombin (0.5 U/ml) for 
10 min. The enzyme content of the supernatant  solution was measured after centrifuga- 
tion at 3,000 g for 10 min. Total enzyme content was measured in sonicated  (30 s at 70 
W, Branson Sonifier) platelet suspensions. The values (mean  -4- SE) given are corrected 
for the amount of enzyme activity present in the medium before any treatment.  Number 
of experiments:  lactate dehydrogenase,  9; pyruvate kinase, 6; malate  dehydrogenase,  5. 
FmuR]a 5.  Effect of EGTA and EGTA -b Mg  ~+ on A23,187-induced release of platelet 
[14C]serotonin. Platelet suspensions incubated at 37°C for 10 min with varying concentra- 
tions ofA23,187.  No calcium or magnesium added.  EGTA (1 mM) or EGTA  +  Mg  ~+ 
(1 mM) added 2 rain before the ionophore. Values are means -4- SE for eight experiments. 
the  presence  of albumin  except  for  somewhat  lower  initial  levels  of the  en- 
zymes in the extracellular fluid of untreated cells.  Presumably  this was due to 
better preservation  of the platelets under these conditions. 
Effects  of EG TA and El)TA  on the Release  Reaction 
With  1 mM  EGTA  in the suspension medium  (no added divalent cations)  the 
release  of calcium  from washed  platelets  by the ionophore was  94.8  4-  6.4% 
(11  experiments)  of that in the absence  of the Ca  2+ chelator  (Table  I).  How- 
ever,  Mg 2+  release  was  decreased  34.2o-/o.  EDTA  (1  raM)  reduced  Ca 2+  re- 
lease by only  11.7°-/o.  Ca 2+ release induced by A23,187  and X537A  is therefore 
apparently  not  dependent  upon  initial  influx  of extracellular  Ca 2+  or  Mg 2+ 
into the platelets.  However,  in the presence  of 1.3 mM  extracellular  Mg ~+ the 
ionophore  released  essentially  all  of  the  platelet  calcium.  EGTA  or  EDTA 
(1  mM)  reduced  the  release  of ADP  by A23,187  (1.6  #M)  from  6.7  (4-0.6) 
nmol/mg  protein to 2.7  (4-0.39)  nmol/mg  protein (six experiments,  Table  I). 
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added calcium also reduced ADP release by the ionophore to  1.56  and  3.1 
nmol/mg  protein  in  two  experiments.  [14C]Serotonin  release  from  washed 
platelets or platelets in  diluted plasma was also substantially,  but not com- 
pletely blocked  by EGTA  or  EDTA  When  the  calcium concentration  (no 
EGTA)  of diluted plasma was raised from an initial level of 0.7  mM to  1.7 
mM,  [14C]serotonin release increased by about  300-/o. In  washed platelets  1 
mM  Mg  2+  +  EGTA  inhibited  serotonin  release  to  a  greater  extent  than 
EGTA  alone  (Fig.  5).  In  the presence of  1-3.3  mM  EGTA  or  EDTA  the 
release of serotinin from platelets in plasma, induced by 2.8 #M A23,187, was 
decreased by 59-71 °-/o (eight experiments). 
Platelet Aggregation 
WASHED PLATELETS  Both A23,187 and X537A produced an increase in light 
transmittance (Fig.  6) when added to washed platelet suspensions at concen- 
trations of 0.4--0.8 #M.  This effect was almost entirely eliminated by EGTA 
or EDTA, and was enhanced by the  addition of calcium above  the 10-20 #M 
level normally present.  Ca  2+,  but not Mg  2+, reversed the inhibitory effect of 
EGTA  Mg 2+  Ca2+ 
EG,  TA  ~  c°2. 
E 
I 
AT:iO~+  5+~ 
0  !  2 3 4 
I  I  I  I  I  I 
MINUTES 
FIGURE 6.  Effects of EGTA, Ca  ~+, Mg  2+, and plasma on aggregation of washed human 
platelet suspensions.  Initial calcium and magnesium concentrations in the extracellular 
fluid were  10-20 pM. A23,187 (1.6 #M)  added at times indicated  by  ,L.  (A) A23,187 
alone.  (B)  MgCI2 (1.3  raM),  CaC12 (1.3  mM).  (C)  CaC12 (1.3  raM).  (D) EGTA (0.7 
raM), MgC12 (1.3 raM), CaC12 (1.3 raM).  (E) Same experiment as D only CaCI2 (1.3 
mM),  rather than Mg  2+, was added after the ionophore. Note prior addition of Mg  2+ 
(1.3 raM) in D decreases response to subsequent addition of Ca  2+. (F) 0.5 vol of platelet- 
free plasma added to 2.5 vol of washed platelet suspension before addition of A23,187. 
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EGTA or EDTA. Mg  2+ also tended to oppose the effect of Ca  2+ (Fig. 6). The 
transmittance changes induced by the ionophores were never as great as that 
produced by thrombin, and large  aggregates visible by eye were not usually 
seen. After addition of 15~o plasma (platelet free) to the suspending medium 
the ionophore produced an aggregation pattern like that  of thrombin (Fig. 
6 F) and large aggregates were easily visible by eye. The effect of plasma was 
not prevented by hirudin (25 AT U/ml) and was therefore not due to genera- 
tion of thrombin. Gel-filtered platelets (Tangen et al.,  1971)  were induced to 
secrete maximally without aggregation by 5-rain exposure to  thrombin (0.5 
U/ml)  in  the  presence of  1.0  CTA  (Committee on  Thrombolytic Agents) 
U/ml plasmin (Miller et al.,  1975).  Such platelets, which lost 65% of their 
total  adenine .nucleotide  content  and  86~o  of  their  [t4C]serotonin,  were 
separated  from  the  incubation  medium  by  a  second  filtration  through 
Sepharose-2B gel.  Platelets  treated  in  this  way no  longer  aggregated  with 
thrombin or collagen, but did aggregate normally in the presence of A23,187 
(an effect potentiated by the addition of plasma) without the release of any 
additional detectable ADP. 
PLATELETS IN PLASMA  The addition of Ca  2+ ionophores to platelet-rich 
plasma,  or  platelet  concentrates  diluted with  buffered  physiological saline 
solution  containing  albumin  and  apyrase,  resulted  in  rapid  aggregation. 
Maximal aggregation was usually produced within 2 min  by concentrations 
of 1.5--7 #M A23,187.  Ionophore-induced aggregation of platelets in plasma 
required Ca  2+ in the medium as in the case of collagen-, thrombin-, or epi- 
nephrine-induced aggregation. 
Inhibition of Platelet Release  Reaction  and Aggregation  by PGE1 ahd Dibutyryl 
Cyclic AMP 
The  release  of [14C]serotonin byA23,187  was  prevented  by  PGE1  and  di- 
butyryl cAMP, an effect enhanced by theophylline (Fig.  7).  Low concentra- 
tions of PGE 1 substantially reduced the extent of A23,187-induced aggregation 
of platelets  in  plasma  (Figs.  8-10).  Marked  inhibition  of aggregation was 
produced by 1-2-rain preincubation of platelets with PGEI before the addition 
of the ionophore. Theophylline at a  concentration of 8.3  X  10  -4 M  usually 
had little or no inhibitory effect by itself, but resulted in a  10-fold potentiation 
of the effect of PGE1 (Figs. 8, 9). Increasing the ionophore or Ca  2+ concentra- 
tion tended to partially reverse the effect of PGE~. But the degree of reversal 
decreased as the PGE1 concentration increased, and it was much less when 
theophylline was present as well (Figs. 9,  10). 
The ionophores, like other aggregating agents, cause an initial decrease of 
light transmittance and an abolition of spontaneous transmittance oscillations. 
These  effects  are  indicative of a  change  in  platelet  shape  from discoid  to 
sphere (Born, 1970).  The ionophore-induced shape change was not blocked by 
PGE~ or PGE1  -t-  theophylline (Figs.  8-10).  When platelet aggregation was 572  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  66  -  i975 
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FIGURE 7.  Release of [x4C]serotonin from platelets in plasma by A23,187.  A23,187 con- 
centrations are given above the bars which represent the percent of total radioactive 
serotonin release (eight experiments, mean  -4- SE)  in 5 min. PGEI  (4.6  ×  10  -s M)  .t_ 
theophylline (0.83 mM) added 2 min before A23,187.  Dibutyryl cAMP (0.7 mM) added 
60  min before  A23,187.  Controls incubated for  60  min exhibited normal ionophore- 
induced release of [14C]serotonin. Temperature 37°C. 
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FIGURE 8.  Inhibition of platelet aggregation by PGE1.  A23,187 added at the arrows 
(  ~. ).  (a-d)  Diluted platelet concentrate (1.39  ×  l0 s platelets/ml). PGEx and theophyl- 
line addition, were made 2 min before A23,187.  (a)  Control. (b) PGE~ 4.6  X  10  -8 M. 
(c)  PGEI 4.6  X  10  -7 M.  (d)  q-PGE~  4.6  X  10  -8 M  -b theophylline 8.3  X  10  -4 M. 
(e-f)  Platelet-rich plasma treated with A23,187  or ADP (10 pM).  (g)  4.6  ×  10  -7 M 
PGEx added 2 min before the ionophore. 573 
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FIOURE 9.  Effect ofionophore concentration on PGEx inhibition ofplatelet aggregation. 
Diluted platelet concentrate  (2.8  ×  10 s platelets/ml).  (a)  Control.  (b)  PGEI  4.6  X 
10  -s M. (c) PGEz 4.6  X  10  -7 M. (d) Theophylline 8.3  X  10  -4 M. (e) PGE~ 4.6  X  10  -~ 
M  d- theophylline 8.3  ×  10  -4 M. PGE1 and theophylline were added 2 rain before the 
first addition of A23,187 ($). 
completely  inhibited  the  spontaneous  oscillations  gradually  increased  to 
normal again after several minutes (Figs. 8 d,  10f). Thus, under these condi- 
tions the ionophore-induced shape change was spontaneously reversible. 
Dibutyryl cAMP also strongly inhibited ionophore-induced platelet aggre- 
gation.  The  effect  was  dependent  upon  both  the  concentration  of 
cyclic nucleotide and  the time of incubation,  due to its  slow accumulation 
within platelets (Salzman and Levine,  197 I).  Incubation with cyclic nucleo- 
tide for 60 min greatly increased the inhibition of ionophore-induced aggrega- 
tion (Fig. 11), whereas controls were unaffected by such prolonged incubation 
at  37°C.  Theophylline  also  potentiated  the  inhibitory  action  of dibutyryl 
cAMP so that striking effects were produced at nucleotide concentrations as 
low as 3  ×  10 -5 M  (Fig.  11). Inhibition of ionophore-induced platelet aggre- 
gation  by dibutyryl cAMP  plus  theophylline was only weakly  reversed  by 
increasing Ca  2+ or ionophore concentrations. 574  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  66  -  I975 
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FIaURE  10.  Effect of Ca  2+ on the inhibition by PGEL of A23,187-induced aggregation 
Diluted platelet concentrate (3.0  X  10 s platelets/ml). A23,187 added at the arrows.  (a) 
Control,  calcium concentration of the extracellular fluid was 0.7 mM.  (b)  PGE1 4.6  X 
10  -s M. (c) PGE1 4.6  X  10  .8 M. (d) PGE1 4.6  X  10  -s M  +  theophyIline 8.3  X  10  .4 M. 
(e) PGE1 4.6  X  10  -8  M.  (f) PGEI  4.6  X  10  -s M  +  theophylline 8.3  X  10  -4 M. PGE. 
and theophylline were  added  2 min before A23,187. An additional  1.0 mM CaCI2  was 
added as indicated to increase the extracellular calcium concentration to 1.7 mM. 
Other Inhibitors of Platelet Release Reaction  and Aggregation 
N-ethyl maleimide NEM (6.7 >< 10 .5 M to 2.7 >< 10 .4 M) was an effective inhib- 
itor of A23, 187-induced calcium release from washed platelets, and  [I4C]sero- 
tonin release and aggregation in platelets in diluted plasma. Aspirin (lmM) and 
indomethacin (10 .4 M) had a weak inhibitory effect which was only apparent 
at low concentrations of A23,187 which did not produce full aggregation. This 
lack of effect was in marked contrast to their total inhibition of low concentra- 
tions of collagen (30 #g)  which induced aggregation equivalent in degree to 
that  evoked by 5  #M  A23,187.  It  suggests  that  ionophore-induced platelet 
aggregation occurs independent of intracellular prostaglandin synthesis. FEINSTEIN AND  FRASER  Human  Platelet Secretion and Aggregation 
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FIGURE  11.  Inhibition of ionophore-induced aggregation by dibutyryl cAMP.  (a-f): 
A23,187 (6 #M) added at arrows ( ~ ) to diluted platelet concentrates (1.6  X  108 plate- 
lets/m/). (a) I  X  10  -4 M  dB-cAMP 5 min before A23,187. (b) dB-cAMP 3.3  X  10  -4 M. 
(c) dB-cAMP 6.6  X  10  -4 M.  (d) Control response of platelets preincubated at 37°C for 
60 rain. (e) dB-cAMP 3  X  10  -5 M.  (f) dB-cAMP 8  X  10  -5 -t- theophylline 8.3  X  10  -4 
M.  (g-h):  Diluted platelet  concentrate  (2.5  X  l0 s platelets/ml).  (g)  Control platelet 
aggregation.  (h)  Upper-addition A23,187 ( ¢ ) 30 rnin after incubation with 8  X  10  -5 M 
dB-cAMP lower 30 rain after incubation with dB-cAMP 8  ×  l0  -5 M  -t-  theophylline 
8.3  X  10  -4 M. 
DISCUSSION 
The Ca  2+,  Mg  ~+ ionophores A23,187 and X537A elicit a pattern of secretion 
from human platelets which is  in  most respects  indistinguishable from the 
normal  physiological  release  reaction.  The  release  of adenine  nucleotides 
(ADP and ATP), serotonin, calcium, and/~-glucuronidase was equivalent in 
quantity and time-course to  that produced by thrombin.  Furthermore, the 
release process was selective in that cytoplasmic constituents such as lactate 
and  malate dehydrogenases, pyruvate kinase,  and  zinc,  which escape from 
lysed platelets, were not released by the ionophores. A23,187  also increased 576  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  '  VOLUME  66  •  ~975 
the  uptake,  or  exchange,  of calcium  (measured  as  45Ca) in  platelets.  The 
partial  dependence of ionophore-induced secretion on  extracellular  Ca 2+ was 
demonstrated  by  two  observations:  the  inhibition  by  EGTA  of ADP  and 
serotonin  release,  and  the  increased  release  of serotonin  due  to  elevation  of 
extracellular  Ca  2+.  However,  a  significant  degree  of platelet  secretion  per- 
sisted in the presence of EGTA or EDTA concentrations  greatly in excess  of 
the extracellular  divalent cation  concentration.  Ionophore-induced  secretion 
is  therefore  different,  in  the  degree  of its  dependency on  extracellular  Ca 2+ 
from that elicited by thrombin or collagen. The release reaction due to throm- 
bin is not inhibited  by EGTA in human platelets (Morse et  al.,  1965; Miller 
et al.,  1975)  and presumably depends upon mobilization  of intracellular  cal- 
cium,  whereas we found  the  release  of serotonin  by collagen  to  be  entirely 
abolished  by  EGTA.  A  greater  extracellular  Ca  2+  dependency,  for  the 
thrombin-induced  release  reaction  is  observed  in  pig  platelets  (Kinlough- 
Rathbone et al.,  1973).  The large loss of cellular  magnesium  which accom- 
panies  the  ionophore-induced  release  reaction  does  not  occur  in  platelets 
stimulated  by thrombin.  The  ionophores  also  act  as  mobile  Mg  2+  carriers 
(Reed and Lardy,  1972; Pressman,  1973) which undoubtedly accounts for the 
large magnesium loss which is not directly related to the secretory process. 
Ionophores may release stored amines from cells by a nonexocytotic mecha- 
nism (Thoa et al.,  1974), attributable to their ability to complex some organic 
amines such  as norepinephrine  and  epinephrine  (Pressman,  1973).  We have 
found (Feinstein and Fraser, unpublished observations) that both X537A and 
A23,187  can  transport  serotonin  from water into  an  immiscible  organic  sol- 
vent. A23, 187 was much weaker than X537A in this respect, and its ability to 
transport  serotonin  was inhibited  by Ca  2+  (50  #M)  but was not affected by 
PGE1 or dibutyryl cAMP.  Serotonin release from platelets by A23, 187 there- 
fore has the characteristics of ~he physiological release process and not a direct 
transport  of the  amine  by the ionophore.  Further  experiments will be neces- 
sary to determine to what extent,  if any, X537A acts as a  carrier  to transport 
serotonin out of platelets. However, neither the release of adenine nucleotides, 
nor the aggregation of platelets induced by the ionophores occurs secondarily 
as  a  result  of serotonin  release.  This  conclusion  is  based  on our observation 
(unpublished  experiments)  that  nigericin  releases  serotonin  from  platelets, 
but not Ca  ~+ or adenine  nucleotides, nor does this  ionophore induce platelet 
aggregation. 
The  release  of serotonin  and  ADP  by A23,187  was  reduced  by EGTA, 
EDTA, or Mg  ~+ without a significant decrease in the amount of Ca  "+ released. 
This  may indicate  that  a  fraction  of platelet calcium originates  from sources 
other  than  the  secretory  granules,  or  that  the  ionophore  may  have  gained 
access to  the  granule  membranes  and  thereby selectively transported  intra- 
granular calcium out of the cell. In this case it must be assumed that release of FEINSTEIN AND FRASER  Human Platelet Secretion and Aggregation  577 
Ca  2+  from the  secretory granules  into  the  cytoplasm could  occur  without 
incurring the full release reaction. Further work will be required to identify the 
intracellular  sources  of ionophore-releasable Ca  2+.  Detwiler  and  Feinman 
(I 973)  reported that the release of Ca  ~+ from thrombin-stimulated platelets 
preceded in  time the release of ATP,  and  Steiner and Tateishi  (1974)  ob- 
served that epinephrine and collagen released the same amount of serotonin as 
thrombin, but much less calcium. These findings also argue for the existence of 
extragranular pools  of calcium which may be involved  in  stimulus-secretion 
coupling. Extragranular sources of calcium may include mitochondria or the 
ATP-dependent calcium-accumulating  vesicles which have been isolated from 
disrupted platelets (Statland et al.,  1969; Robblee et al.,  1973 a).  The latter 
has properties which are analogous in many ways to the calcium "pump" of 
sarcoplasmic retieulum (SR), but has not as yet been positively identified with 
any specific .anatomic structure. The system of so-called dense tubules seen in 
high magnification electron micrographs of platelets are intimately associated 
with the surface-connecting open canilicular system (White, 1973). The close 
apposition of these membranes has been likened to the T  tubule, SR associa- 
tion  in  muscle.  The lipophilic  ionophore  molecules would  be  expected to 
readily gain  access  to  the  membranes of the dense tubular  system via  the 
system of open canals. If the dense tubular system comprises a calcium sink for 
the  cell,  then  the  ionophores might be  able  to  discharge a  portion  of the 
accumulated Ca  ~+ into the cytoplasm. A23,187 and X537A cause the release 
of Ca  2+ previously transported into  SR  fragments from skeletal or cardiac 
muscle  (Scarpa et al.,  1972; Entman et  al.,  1972; Pressman,  1973). Iono- 
phore-mediated transport of intracellularly sequestered Ca  2+  into  the cyto- 
plasm probably serves as  the trigger for that fraction of the platelet release 
reaction which is independent of extracellular calcium. 
A  functional analogy with muscle is further indicated by  the presence in 
platelets of contractile proteins which have the properties of myosin,  actin, 
tropomyosin, and a protein factor conferring Ca  2+ sensitivity (Thorens et al., 
1973). Activation of the Ca2+-dependent contractile system has been proposed 
to be involved in the morphological changes of platelets, induced by various 
stimuli  (White,  1971), leading to secretion and  aggregation.  Mg~+-ATPase 
activity  of platelet  actomyosin  is  low  compared  to  Ca2+-ATPase  activity 
(Abramowitz et al.,  1972) which may account for the inhibition of ionophore- 
induced secretion by a  high Mg2+/Ca  2+ ratio  in  the  medium.  Under such 
conditions the essentially complete depletion of cellular Ca  2+  (see  Table  I) 
would be highly unfavorable for ATPase activity. The mechanism of action of 
NEM as an inhibitor of platelet secretion and aggregation may also be related 
to  the  platelet contractile proteins since  their  ATPase  activity and  super- 
precipitation has  been reported to  be  inhibited  by this  agent  (Booyse  and 
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Inhibition of platelet aggregation by PGEI and dibutyryl cAMP could in 
itself  effect  the  ionophore-induced  release  reaction  since  Packham  et  al. 
(1973)  reported  that  cellular  aggregation  enhances  secretion  from  rabbit 
platelets.  However,  we  find  that  the  time-course of the  release  evoked  by 
ionophores precedes the  time-course of the  aggregation  process.  Moreover, 
cellular aggregation is not necessarily an absolute prerequisite for the release 
reaction  in  human  platelets  since  thrombin-induced  secretion  occurs  un- 
impeded in the presence of EGTA or plasmin, both of which prevent aggrega- 
tion (Miller et al.,  1975).  Additional study will be required to determined the 
extent  to  which  cell-cell  contact  influences  the  ionophore-induced  release 
reaction. 
Holmsen (1974)  has proposed that shape change, the release reaction and 
aggregation are all manifestations of one basic ATP-requiring reaction (i.e., 
cellular  contraction)  initiated  by  Ca  2+  released  from  membrane  vesicles. 
These platelet functions are viewed as being a  function of stimulus intensity 
and in parallel with each other, rather than in series. The role of Ca  ~+ as the 
initiator of all of these processes is substantiated by the results obtained with 
Ca  2+  ionophores.  Furthermore  our  findings  are  consistent  with  Holmsen's 
view  in  that  ionophore-induced  secretion  and  aggregation  can  occur  in- 
dependently of each other under certain experimental conditions. The latter 
case (aggregation without release) was found to occur in response to A23,187 
in gel-filtered platelets previously exhausted of their releasable pool of ADP. 
Several facts link the effect of PGE1 to cAMP metabolism. PGE1 is a power- 
ful stimulant of platelet adenyl cyclase activity (Haslam,  1973),  and increases 
intraplatelet levels of cyclic 3' ,5'-AMP  (Butcher et al.,  1967;  Vigdahl et al., 
1969).  Elevated cAMP levels in  the platelet are well correlated with PGEI 
inhibition  of aggregation  (Vigdahl et al.,  1969).  Both PGErinduced cAMP 
synthesis and inhibition of platelet aggregation and secretion are potentiated 
by phosphodiesterase  inhibitors  (Ball et al.  1970; Marquis et al.,  1969;  Salz- 
man et al.,  1970).  The ability of both PGE~ and dibutyryl cAMP to inhibit 
secretion and aggregation due to Ca2+-ionophores indicates that high cellular 
concentrations  of  cAMP  probably  modify  passive  or  active  cellular  Ca  2+ 
transport,  or some Ca2+-dependent  processes which may involve contractile 
proteins.  Alternatively, cAMP inhibits an essential process beyond the Ca  2+- 
requiring  steps.  Further  studies  on  the  complex  interrelationships  between 
Ca  ~+ and cyclic nucleotides should provide much greater insight into normal 
physiological processes in the platelet. 
Note Added in Proof  Since the presentation of this manuscript for publication two 
papers have appeared concerning X537A and A23,187  effects on platelets (Massini, 
P. and E. F. Luscher. 1974. Biochim.  Biophys.  Acta.  372:109,  and White, J. G., Gundu 
H. R. Rao, and Jonathan M. Gerrard. 1974. Am. 3". Path& 77:135).  Our results are, 
for the most part, in excellent agreement with the above studies. FEINSTEIN AND FRASER  Human Platelet Secretion and Aggregation  579 
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